Form Bio
PrivateLast Round
Series A
Sep 27, 2022
Total Funding Raised
$30M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Form Bio operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Series A round in September 2022.
Form Bio is a biotechnology company that develops artificial intelligence-powered tools to enhance AAV gene therapy development through predictive modeling, automated candidate optimization, and virtual biomanufacturing.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Form Bio Comparables
Compare Form Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asimov | 84% | |
| LatchBio | 81% | |
| Tamarind Bio | 80% |
For institutional investors. Book with your work email.
Form Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Form Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Series A |
| JAZZ Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Secured a multi-million dollar annual software services contract.
- Aug 18, 2025
Michelle Chen appointed President, CEO, and Board member.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 28, 2026
On Sep 28th '26, Form Bio, Inc.'s leadership team is set to attend Cell & Gene Meeting on the Mesa 2026 and showcase its integrated approach to gene therapy development.
For institutional investors. Book with your work email.
Form Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Form Bio's valuation, stock price, and market status.
Is Form Bio a public or private company?
Form Bio is a private company.
What is the current stock price of Form Bio?
Form Bio is a private company, so its shares have no public market price. Caplight tracks Form Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Form Bio worth (valuation)?
Valuation information for Form Bio is not publicly available.
Can I buy Form Bio stock?
Form Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Form Bio's last funding round?
Form Bio's most recent funding round was Series A on September 27, 2022.
Who are the main investors in Form Bio?
Key investors in Form Bio include JAZZ Venture Partners.
Will Form Bio IPO soon?
No public IPO plans have been announced for Form Bio.
How can I track Form Bio secondary market activity?
Caplight tracks bids, offers, and trades in Form Bio's shares on secondary markets.